Clark Capital Management Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $650K | Buy |
23,157
+276
| +1% | +$7.35K | ﹤0.01% | 349 |
|
|
2025
Q4 | $570K | Sell |
22,881
-4,399
| -16% | -$111K | ﹤0.01% | 355 |
|
|
2025
Q3 | $695K | Sell |
27,280
-2,519
| -8% | -$62.2K | ﹤0.01% | 318 |
|
|
2025
Q2 | $722K | Sell |
29,799
-2,233
| -7% | -$52.1K | 0.01% | 311 |
|
|
2025
Q1 | $812K | Buy |
32,032
+978
| +3% | +$25.6K | 0.01% | 310 |
|
|
2024
Q4 | $824K | Sell |
31,054
-1,186
| -4% | -$32.2K | 0.01% | 309 |
|
|
2024
Q3 | $933K | Buy |
32,240
+461
| +1% | +$13.4K | 0.01% | 301 |
|
|
2024
Q2 | $889K | Buy |
31,779
+15,525
| +96% | +$427K | 0.01% | 286 |
|
|
2024
Q1 | $451K | Sell |
16,254
-7,555
| -32% | -$210K | ﹤0.01% | 333 |
|
|
2023
Q4 | $685K | Sell |
23,809
-686,282
| -97% | -$20.7M | 0.01% | 298 |
|
|
2023
Q3 | $23.6M | Buy |
710,091
+13,268
| +2% | +$469K | 0.24% | 134 |
|
|
2023
Q2 | $25.6M | Buy |
696,823
+20,162
| +3% | +$785K | 0.23% | 128 |
|
|
2023
Q1 | $27.6M | Buy |
676,661
+11,585
| +2% | +$500K | 0.31% | 118 |
|
|
2022
Q4 | $34.1M | Buy |
665,076
+25,784
| +4% | +$1.24M | 0.31% | 88 |
|
|
2022
Q3 | $28M | Sell |
639,292
-302,292
| -32% | -$14.7M | 0.37% | 80 |
|
|
2022
Q2 | $49.4M | Buy |
941,584
+109,245
| +13% | +$5.57M | 0.65% | 28 |
|
|
2022
Q1 | $43.1M | Buy |
832,339
+253,926
| +44% | +$13.2M | 0.48% | 48 |
|
|
2021
Q4 | $34.2M | Buy |
578,413
+568,479
| +5,723% | +$28.2M | 0.42% | 85 |
|
|
2021
Q3 | $427K | Buy |
9,934
+427
| +4% | +$18.9K | 0.01% | 288 |
|
|
2021
Q2 | $372K | Buy |
9,507
+1,484
| +18% | +$57.7K | 0.01% | 309 |
|
|
2021
Q1 | $291K | Sell |
8,023
-562,035
| -99% | -$20M | ﹤0.01% | 317 |
|
|
2020
Q4 | $21M | Sell |
570,058
-40,095
| -7% | -$1.47M | 0.35% | 124 |
|
|
2020
Q3 | $21.2M | Sell |
610,153
-740
| -0.1% | -$25.9K | 0.4% | 105 |
|
|
2020
Q2 | $19M | Buy |
610,893
+4,344
| +0.7% | +$148K | 0.35% | 114 |
|
|
2020
Q1 | $18.8M | Sell |
606,549
-8,403
| -1% | -$286K | 0.48% | 75 |
|
|
2019
Q4 | $22.9M | Buy |
614,952
+6,747
| +1% | +$240K | 0.48% | 78 |
|
|
2019
Q3 | $20.7M | Sell |
608,205
-671,837
| -52% | -$24.4M | 0.47% | 85 |
|
|
2019
Q2 | $52.6M | Buy |
1,280,042
+378,310
| +42% | +$15M | 1.11% | 19 |
|
|
2019
Q1 | $36.3M | Sell |
901,732
-535,687
| -37% | -$21.5M | 0.87% | 37 |
|
|
2018
Q4 | $59.5M | Sell |
1,437,419
-60,577
| -4% | -$2.51M | 1.6% | 10 |
|
|
2018
Q3 | $62.6M | Buy |
1,497,996
+1,486,759
| +13,231% | +$57.2M | 1.59% | 10 |
|
|
2018
Q2 | $387K | Sell |
11,237
-2,676
| -19% | -$91.4K | 0.01% | 239 |
|
|
2018
Q1 | $468K | Sell |
13,913
-685
| -5% | -$23.5K | 0.01% | 244 |
|
|
2017
Q4 | $502K | Buy |
14,598
+3,187
| +28% | +$109K | 0.02% | 234 |
|
|
2017
Q3 | $386K | Buy |
11,411
+1,467
| +15% | +$47.1K | 0.01% | 259 |
|
|
2017
Q2 | $317K | Sell |
9,944
-2,018
| -17% | -$63.6K | 0.01% | 238 |
|
|
2017
Q1 | $388K | Sell |
11,962
-713,964
| -98% | -$22.5M | 0.02% | 242 |
|
|
2016
Q4 | $22.4M | Buy |
725,926
+103,384
| +17% | +$3.16M | 1.16% | 15 |
|
|
2016
Q3 | $20M | Buy |
622,542
+109,731
| +21% | +$3.67M | 1.15% | 15 |
|
|
2016
Q2 | $17.1M | Buy |
512,811
+221,775
| +76% | +$7.08M | 1.11% | 15 |
|
|
2016
Q1 | $8.18M | Sell |
291,036
-79,520
| -21% | -$2.27M | 0.63% | 59 |
|
|
2015
Q4 | $11.3M | Buy |
370,556
+338,213
| +1,046% | +$10.6M | 0.92% | 23 |
|
|
2015
Q3 | $964K | Buy |
32,343
+1,926
| +6% | +$61.8K | 0.09% | 172 |
|
|
2015
Q2 | $968K | Sell |
30,417
-1,830
| -6% | -$59.6K | 0.09% | 174 |
|
|
2015
Q1 | $1.06M | Sell |
32,247
-2,176
| -6% | -$69.2K | 0.1% | 173 |
|
|
2014
Q4 | $1.02M | Sell |
34,423
-7,763
| -18% | -$223K | 0.09% | 134 |
|
|
2014
Q3 | $1.18M | Sell |
42,186
-3,756
| -8% | -$105K | 0.1% | 120 |
|
|
2014
Q2 | $1.29M | Sell |
45,942
-247,328
| -84% | -$7.05M | 0.11% | 125 |
|
|
2014
Q1 | $8.94M | Buy |
293,270
+7,227
| +3% | +$215K | 0.77% | 31 |
|
|
2013
Q4 | $8.31M | Buy |
286,043
+11,816
| +4% | +$344K | 0.69% | 31 |
|
|
2013
Q3 | $7.47M | Buy |
274,227
+14,971
| +6% | +$407K | 0.59% | 38 |
|
|
2013
Q2 | $6.89M | Buy |
+259,256
| New | +$7.16M | 0.63% | 36 |
|
Other funds holding PFE
VCM
VPM
Clark Capital Management Group's PFE Position: Q1 2026 in Review
Clark Capital Management Group increased its Pfizer (PFE) stake by 1.2% in Q1 2026, buying an estimated $7.35K and bringing the position to 23,157 shares worth $650K. The position accounts for ﹤0.01% of the portfolio, ranked #349.
Clark Capital Management Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $62.6M in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Clark Capital Management Group held 23,157 shares of Pfizer worth $650K as of Q1 2026.
- Clark Capital Management Group bought 276 Pfizer shares in Q1 2026, an estimated $7.35K.
- Pfizer made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #349 holding.
- Clark Capital Management Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Clark Capital Management Group's Pfizer position peaked at $62.6M in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.